BioSpace News Archive

Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today provided Company updates and reported consolidated financial results for the year ended December 31, 2022.

STALICLA and Firefly Neuroscience today announced a partnership to further validate EEG-based biomarkers in biologically enriched subgroups of patients with Autism Spectrum Disorder (ASD).

Todos Medical, Ltd. today announced that its Ordinary shares will begin trading on the OTC Pink marketplace beginning on March 27, 2023 as a result of the Company’s closing bid price falling below $0.001 for 5 consecutive trading days, from March 20, 2023 through March 24, 2023.

Reneo Pharmaceuticals, Inc. today reported financial results for the quarter and year ended December 31, 2022 and provided a business update.

Cytokinetics, Incorporated announced the release of its inaugural Corporate Responsibility Report, outlining the Company’s commitment to social and environmental responsibility, ethics and governance and patient and community engagement.

Olink Holding AB announced that the Annual Report for 2022 is now available on the Company’s website.

Covalon Technologies Ltd. today announced the second expert-led webinar in its CLABSI Conscious campaign, titled “Protecting CVADs from Gross Contamination”, to be held on Wednesday, March 29 at 1pm EDT.

Avacta Group plc announces it will present a poster entitled ‘AVA3996, a novel pre|CISION™ medicine, targeted to the tumor microenvironment via Fibroblast Activation Protein-alpha (FAP-a) mediated cleavage’ , at the American Association for Cancer Research (AACR) 2023 Annual Meeting, taking place at Orange County Convention Center, Orlando, Florida.

Vaxxinity, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022.

Prime Medicine, Inc. announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will present a corporate overview at the Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days on Monday, April 3, 2023 at 3:55 p.m. ET in New York, NY.